Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies.
about
Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells.Pegylated liposomal‑paclitaxel induces ovarian cancer cell apoptosis via TNF‑induced ERK/AKT signaling pathway.Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.
P2860
Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@ast
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@en
type
label
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@ast
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@en
prefLabel
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@ast
Drug delivery systems for ovar ...... ta-analysis of animal studies.
@en
P2093
P2860
P356
P1433
P1476
Drug delivery systems for ovar ...... eta-analysis of animal studies
@en
P2093
Leon F Massuger
Rob B M de Vries
Toin H van Kuppevelt
P2860
P356
10.7717/PEERJ.1489
P577
2015-12-10T00:00:00Z